Abstract
Schizophrenia is a severe mental disorder that is likely to be strongly determined by genetic factors. To identify markers of disks, large homolog 2 (DLG2), FAT atypical cadherin 3 (FAT3), kinectin1 (KTN1), deleted in colorectal carcinoma (DCC), and glycogen synthase kinase-3β (GSK3β) that contribute to the genetic susceptibility to schizophrenia, we systematically screened for polymorphisms in the functional regions of these genes. A total of 22 functional single-nucleotide polymorphisms (SNPs) in 940 Chinese subjects were genotyped using SNaPshot. The results first suggested that the allelic and genotypic frequencies of the DCC polymorphism rs2229080 were nominally associated with schizophrenia. The patients were significantly less likely to be CC homozygous (P = 0.005, odds ratio [OR] = 0.635, 95 % confidence interval [95 % CI] = 0.462–0.873), and the schizophrenia subjects exhibited lower frequency of the C allele (P = 0.024, OR = 0.811, 95 % CI = 0.676–0.972). Regarding GSK3β, there was a significant difference in genotype distribution of rs3755557 between schizophrenia and healthy control subjects (P = 0.009). The patients exhibited a significantly lower frequency of the T allele of rs3755557 (P = 0.002, OR = 0.654, 95 % CI = 0.498–0.860). Our results point to the polymorphisms of DCC and GSK3β as contributors to the genetic basis of individual differences in the susceptibility to schizophrenia.
Similar content being viewed by others
References
Alemany S, Ribases M, Vilor-Tejedor N, et al. (2015) New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. doi:10.1002/ajmg.b.32341
Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura Y (2012) A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. J Hum Genet 57:235–237
De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A (2012) Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Design 18:486–494
Deans MR, Krol A, Abraira VE, Copley CO, Tucker AF, Goodrich LV (2011) Control of neuronal morphology by the atypical cadherin Fat3. Neuron 71:820–832
Djansugurova L, Zhunussova G, Khussainova E, et al. (2015) Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan. Tumor Biol 36:279–289
Dobson-Stone C, Polly P, Korgaonkar MS, et al. (2013) GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals. PLoS One 8:e71750
Egger G, Roetzer KM, Noor A, et al. (2014) Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families. Neurogenetics 15:117–127
Fiorentini M, Bach A, Stromgaard K, Kastrup JS, Gajhede M (2013) Interaction partners of PSD-93 studied by X-ray crystallography and fluorescence polarization spectroscopy. Acta crystallographica Section D, Biological crystallography 69:587–594
Flores C, Manitt C, Rodaros D, et al. (2005) Netrin receptor deficient mice exhibit functional reorganization of dopaminergic systems and do not sensitize to amphetamine. Mol Psychiatry 10:606–612
Global Burden of Disease Study C (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800
Grant A, Fathalli F, Rouleau G, Joober R, Flores C (2012) Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophr Res 137:26–31
Grant A, Speed Z, Labelle-Dumais C, Flores C (2009) Post-pubertal emergence of a dopamine phenotype in netrin-1 receptor-deficient mice. Eur J Neurosci 30:1318–1328
Hamasaki T, Goto S, Nishikawa S, Ushio Y (2001) A role of netrin-1 in the formation of the subcortical structure striatum: repulsive action on the migration of late-born striatal neurons. J Neurosci Off J Soc Neurosci 21:4272–4280
Hibar DP, Stein JL, Renteria ME, et al. (2015) Common genetic variants influence human subcortical brain structures. Nature 520:224–229
Holt DJ, Lebron-Milad K, Milad MR, et al. (2009) Extinction memory is impaired in schizophrenia. Biol Psychiatry 65:455–463
Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III—the final common pathway. Schizophr Bull 35:549–562
Ingason A, Giegling I, Hartmann AM, et al. (2015) Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia. Transl Psychiatry 5:e656
Iwahashi K, Nishizawa D, Narita S, et al. (2014) Haplotype analysis of GSK-3 beta gene polymorphisms in bipolar disorder lithium responders and nonresponders. Clin Neuropharmacol 37:108–110
Kang HJ, Kawasawa YI, Cheng F, et al. (2011) Spatio-temporal transcriptome of the human brain. Nature 478:483–489
Kantrowitz J, Javitt DC (2012) Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr Opin Psychiatry 25:96–102
Kirov G, Pocklington AJ, Holmans P, et al. (2012) De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17:142–153
Kozlovsky N, Belmaker RH, Agam G (2000) Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 157:831–833
Kozlovsky N, Belmaker RH, Agam G (2001) Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr Res 52:101–105
Kozlovsky N, Belmaker RH, Agam G (2002) GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharm 12:13–25
Kumar J, Yu H, Sheetz MP (1995) Kinectin, an essential anchor for kinesin-driven vesicle motility. Science 267:1834–1837
Kwok JB, Loy CT, Hamilton G, et al. (2008) Glycogen synthase kinase-3beta and tau genes interact in Alzheimer’s disease. Ann Neurol 64:446–454
Lachman HM, Pedrosa E, Petruolo OA, et al. (2007) Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144B:259–265
Lee KY, Ahn YM, Joo EJ, et al. (2006) No association of two common SNPs at position −1727 A/T, −50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 395:175–178
Li M, Mo Y, Luo XJ, et al. (2011) Genetic association and identification of a functional SNP at GSK3beta for schizophrenia susceptibility. Schizophr Res 133:165–171
Lichtenstein P, Yip BH, Bjork C, et al. (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373:234–239
Lin YF, Huang MC, Liu HC (2013) Glycogen synthase kinase 3 beta gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium. J Affect Disorders 147:401–406
Malik MA, Gupta A, Zargar SA, Mittal B (2013) Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis. Tumor Biol 34:3049–3057
Manitt C, Eng C, Pokinko M, et al. (2013) DCC orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients. Translational psychiatry 3:e338
Manitt C, Mimee A, Eng C, et al. (2011) The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J Neurosci Off J Soc Neurosci 31:8381–8394
Mao YW, Ge XC, Frank CL, et al. (2009) Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3 beta/beta-catenin signaling. Cell 136:1017–1031
Noor A, Lionel AC, Cohen-Woods S, et al. (2014) Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. Am J Med Genet B Neuropsychiatr Genet 165B:303–313
Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore ET, Lawrie SM (2011) Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiat 70:88–96
van Os J, Kapur S (2009) Schizophrenia. Lancet 374:635–645
Owen MJ, Williams HJ, O’Donovan MC (2009) Schizophrenia genetics: advancing on two fronts. Current Opin Genet Dev 19:266–270
Pandey GN, Rizavi HS, Tripathi M, Ren XG (2015) Region-specific dysregulation of glycogen synthase kinase-3 beta and beta-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia. Bipolar Disord 17:160–171
Park SW, Lee JG, Kong BG, et al. (2009) Genetic association of BDNF val66met and GSK-3beta-50 T/C polymorphisms with tardive dyskinesia. Psychiatry Clin Neurosci 63:433–439
Peng YM, Xu YF, Cui DH (2014) Wnt signaling pathway in schizophrenia. Cns Neurol Disord-Dr 13:755–764
Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B (2013) DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. no.: Gene-D-12-01446). Gene 518:303–309
Ramos-Miguel A, Barr AM, Honer WG (2015) Spines, synapses, and schizophrenia. Biol Psychiatry 78:741–743
Schmitt CA, Thaler KR, Wittig BM, Kaulen H, KH M z B, WG D (1998) Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation. Br J Cancer 77:588–594
Shim SH, Hwangbo Y, Kwon YJ, et al. (2012) Association between glycogen synthase kinase-3beta gene polymorphisms and attention deficit hyperactivity disorder in Korean children: a preliminary study. Prog Neuro-Psychopharmacol Biol Psychiatry 39:57–61
Souza RP, Romano-Silva MA, Lieberman JA, Meltzer HY, Wong AH, Kennedy JL (2008) Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology 200:177–186
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187–1192
Szczepankiewicz A, Skibinska M, Hauser J, et al. (2006) Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53:51–56
Tang H, Shen N, Jin H, Liu D, Miao X, Zhu LQ (2013) GSK-3beta polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis. Mol Neurobiol 48:404–411
Tepass U, Truong K, Godt D, Ikura M, Peifer M (2000) Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol 1:91–100
Thomas DC, Witte JS (2002) Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11:505–512
Toyoshima I, Sheetz MP (1996) Kinectin distribution in chicken nervous system. Neurosci Lett 211:171–174
Winterer G, Weinberger DR (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683–690
Zhang H, Arbman G, Sun XF (2003) Codon 201 polymorphism of DCC gene is a prognostic factor in patients with colorectal cancer. Cancer Detect Prev 27:216–221
Zheng WH, Wang HT, Zeng ZW, et al. (2012) The possible role of the Akt signaling pathway in schizophrenia. Brain Res 1470:145–158
Acknowledgments
This research was supported by the National Science Foundation of China (NSFC 81571856 and NSFC 81373247; http://www.nsfc.gov.cn).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written informed consent was obtained from all participants. The study was approved by the Medical Ethics Committee of Xi’an Jiaotong University.
ᅟ
Conflict of Interest
The authors have declared that no conflict of interest exists.
Electronic Supplementary Material
ESM 1
(PDF 171 kb)
Rights and permissions
About this article
Cite this article
Yan, P., Qiao, X., Wu, H. et al. An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia. J Mol Neurosci 59, 366–375 (2016). https://doi.org/10.1007/s12031-016-0751-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-016-0751-6